home / stock / eltp / eltp news

ELTP News and Press, Elite Pharmaceuticals Inc. From 08/14/20

Stock Information
Company Name: Elite Pharmaceuticals Inc.
Stock Symbol: ELTP
Market: OTC
Website: elitepharma.com
Menu
ELTP ELTP Quote ELTP Short ELTP News ELTP Articles ELTP Message Board
Get ELTP Alerts

News, Short Squeeze, Breakout and More Instantly...
ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2021 Ended June 30, 2020 And Provides Conference Call Information

Financials for First Quarter of Fiscal Year 2021 ended June 30, 2020 will be released August 14, 2020 NORTHVALE, NJ / ACCESSWIRE / August 14, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche...
ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2021 Results on August 17, 2020

Financials for First Quarter of Fiscal Year 2021 ended June 30, 2020 will be released August 14, 2020 NORTHVALE, NJ / ACCESSWIRE / August 12, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,...

ELTP - Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q4 2020 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q4 2020 Earnings Conference Call June 30, 2020 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Carter Ward - Chief Financial Officer Conference Call Participants Presentation Operator Good morni...

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for The Fiscal Year Ended March 31, 2020 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, June 30th at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ...
ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 30, 2020

Financials for Fiscal Year Ended March 31, 2020 will be released June 29, 2020 NORTHVALE, NJ / ACCESSWIRE / June 24, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that its...

ELTP - Elite Pharmaceuticals Announces Commercial Launch of Generic Adderall XR(R) with Marketing Partner Lannett Company

NORTHVALE, NJ / ACCESSWIRE / March 31, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) a specialty pharmaceutical company developing niche generic products, announced today that marketing partner Lannett Company, Inc. ("Lannett"), has commenced product launch of El...

ELTP - Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2020 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q3 2020 Earnings Conference Call February 11, 2020, 11:00 ET Company Participants Nasrat Hakim - Chairman, CEO & President Carter Ward - CFO, Secretary & Treasurer Conference Call Participants Presentation Operator Good morni...
ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, February 11th at 11:00 AM EST NORTHVALE, NJ / ACCESSWIRE / February 10, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third...

ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2020 Financial Results on February 11, 2020

Financials for Third Quarter Fiscal Year 2020 Ended December 31, 2020 will be released February 10, 2020 NORTHVALE, NJ / ACCESSWIRE / February 6, 2020 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic pro...

ELTP - Not All Strategic Transformations Are Elite, But This One Is

Having once traded on the AMEX at $20 per share and viewed as an innovative company with a novel technology designed to aid in developing controlled release and abuse-resistant opioids, the competitive environment dramatically changed for Elite Pharma ( ELTP ). Ultimately, their share price dr...
Previous 10 Next 10